Pelamed Pharmaceuticals had EBIT of $324 million in 2018 . In addition, Pelamed had interest expenses of $84.55 million and a corporate tax rate of 25%. a. What is Pelamed's 2018 net income? b. What is the total of Pelamed's 2018 net income plus interest payments? c. If Pelamed had no interest expenses, what would have been its 2018 net income? How does it compare to your answer in part (a)? d. What is the amount of Pelamed's interest tax shield in 2018? a. What is Pelamed's 2018 net income? The 2018 net income is $ million. (Round to the nearest integer.) b. What is the total of Pelamed's 2018 net income plus interest payments? The total of Pelamed's 2018 net income plus interest payments is $ million. (Round to the nearest integer.) c. If Pelamed had no interest expenses, what would have been its 2018 net income? How does it compare to your answer in part (a)? The 2018 net income with no interest expense would be $ million. (Round to the nearest integer.) The 2018 net income with no interest expense is \$ million higher than the 2018 net income with interest expense. (Round to the nearest inteoer.) d. What is the amount of Pelamed's interest tax shield in 2018? Pelamed's interest tax shield in 2018 is $ million. (Round to the nearest integer.)